Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
CHIEF PEOPLE OFFICER · Immuneering Corp · Class A Common Stock
Open-market purchase
$11K reported value · 11.2% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
4 other actors traded the same direction within 14 days
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | Zeskind Benjamin J.Director, PRESIDENT AND CEO | Open-market purchase | BUY | $11K 2,400 sh | Jun 24, 2026 traded Jun 23, 2026 | |
| 9 | Keating LaurieDirector | Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 | |
| 5 | Schall Thomas J.Director | Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 | |
| 9 | Hausman DianaDirector | Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 | |
| 5 | Feinberg PeterDirector | Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 | |
| 9 | Carpenter Robert JDirector | Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 | |
| 62 | Brakewood Harold EugeneChief Business Officer | Open-market purchase | BUY | $25K 5,250 sh | Jan 21, 2026 traded Jan 16, 2026 | |
| 61 | Schall Thomas J.Director | Open-market purchase | BUY | $101K 21.6K sh | Jan 20, 2026 traded Jan 15, 2026 | |
| 44 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Open-market purchase | BUY | $11K 2,298 sh | Jan 16, 2026 traded Jan 15, 2026 | |
| 51 | Feinberg PeterDirector | Open-market purchase | BUY | $87K 20.0K sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 9 | Keating LaurieDirector | Grant or award | A | — 7,888 sh | Jan 2, 2026 traded Jan 1, 2026 | |
| 9 | Feinberg PeterDirector | Grant or award | A | — 7,888 sh | Jan 2, 2026 traded Jan 1, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $10,906
Neufeld Leah R filed this Form 4 reporting a open-market purchase of IMRX on Jan 13, 2026. It became public on Jan 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.